Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Transcription activator GLI1 (also known as GLI proto-oncogene 1) is a zinc-finger transcription factor that serves as the terminal effector of the Hedgehog (Hh) signaling pathway. It plays a critical role in embryonic development, tissue patterning, and cell differentiation. In adult tissues, aberrant activation of GLI1—either through canonical ligand-dependent Hedgehog signaling or non-canonical pathways such as RAS-RAF-MEK-ERK and PI3K-AKT-mTOR—drives oncogenesis, tumor cell proliferation, metastasis, and chemotherapeutic resistance. GLI1 is highly expressed in various malignancies, including basal cell carcinoma, medulloblastoma, pancreatic cancer, and colorectal cancer. While upstream Smoothened (SMO) inhibitors like vismodegib indirectly suppress GLI1 activity, direct GLI1 inhibitors (such as GANT61 and Glabrescione B) and degraders (such as arsenic trioxide) are being actively investigated to overcome SMO-mediated resistance and non-canonical pathway activation.
Direct inhibition of GLI1-DNA binding (e.g., GANT61, Glabrescione B), promotion of GLI1 protein degradation (e.g., arsenic trioxide), or upstream inhibition of Smoothened (SMO) (e.g., vismodegib, sonidegib) to prevent GLI1 nuclear translocation and transcriptional activation.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Transcription activator GLI1 (GLI1).